TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MVIS

Microvision Inc

Technology · Scientific & Technical Instruments · listed since 1996

1.60$ +0.0% vs. previous close Closing price · As of: Sep 17, 2026
🔔 Watch stock
Add to watchlist

Assessment

Our Rating

A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.

Substance risk

We found at least one documented issue that threatens the company itself — regardless of how the stock is currently valued.

Why this colour

Red here stands for documented risk to the substance, not for a judgment on the technology. Three findings converge: cash runway is roughly three quarters ($46.120 million as of March 31, 2026 against $16.443 million of operating outflow per quarter) and shrinks to roughly one and a half once the contractually required minimum cash balance of $21.5 million is deducted, the company expressly names the possibility of being unable to continue as a going concern in its risk section, and the listing hangs on a Nasdaq deadline that the 1-for-15 reverse split has only just satisfied arithmetically. On top of that sits dilution with a mechanism attached: $12.6 million of note debt became 23.6 million shares in seven weeks, and unissued headroom has risen to roughly 553 percent of shares outstanding after the split. The product shelf built through the acquisitions is real and broad, gross profit was clearly positive at $0.363 million in the first quarter of 2026, and with revenue guidance of $10 million to $15 million for 2026 there is a checkable target for the first time — none of which changes the fact that continuing operations currently depend on outside investors being willing to buy new shares. The decision is yours.

What the thesis turns on

Assessment: Opportunities & Risks

MicroVision has collected the technology of two failed lidar suppliers at fire-sale prices and now covers every range — but that is being paid for by the capital markets, not by customers. In fiscal 2025, $1.208 million of revenue faced $18.548 million of cost of revenue and a net loss of $94.981 million; the accumulated deficit reached $982.556 million as of March 31, 2026. Cash of $46.120 million covers roughly three quarters at a burn of $16.443 million per quarter — only about one and a half once the $21.5 million minimum cash covenant is deducted — and the 1-for-15 reverse split of August 1, 2026 was forced by a Nasdaq deadline. Against that stands the company's own guidance of $10 million to $15 million of revenue for 2026 (business update of June 25, 2026), which makes the next quarterly report the test. Not investment advice.

Earning power of the core business

In fiscal 2025, $1.208 million of revenue faced $18.548 million of cost of revenue — a gross loss of $17.340 million. Revenue shrank from $7.259 million (2023) to $1.208 million in two years. In the first quarter of 2026 gross profit was positive again at $0.363 million, but it covered only 1.5 percent of the $23.857 million of operating expenses.

Balance sheet and cash runway

As of March 31, 2026, cash stood at $46.120 million against operating cash outflow of $16.443 million in the quarter — arithmetically just under three quarters, but only roughly one and a half once the contractually required minimum cash balance of $21.5 million is deducted. Current assets ($54.223 million) cover current liabilities ($51.763 million) with a buffer of only about $2.5 million. The accumulated deficit since inception reached $982.556 million.

Dilution and financing

Shares outstanding rose from 194.7 million (end of 2023) to 344.6 million (May 28, 2026). Between March 16 and May 5, 2026, $12.6 million of note debt was converted into 23.6 million shares, leaving $34.7 million outstanding. On top of that sit roughly $42 million of unsold at-the-market capacity (June 12, 2026) and a $50 million shelf (July 13, 2026).

Listing and deadlines

A Nasdaq notification over the $1.00 minimum bid price has been running since January 16, 2026. The transfer to The Nasdaq Capital Market took effect on July 20, 2026, and the 1-for-15 reverse split on August 1, 2026. Compliance is only regained once the closing price reaches at least $1.00 on ten consecutive business days.

Technology and product shelf

After two acquisitions out of insolvency — Scantinel Photonics for $2.244 million (January 2026) and the Luminar lidar business for $33.177 million (closed February 3, 2026) — MicroVision covers every range from short to very long. Whether the price was right is open: the company's own pro forma calculation puts combined first-quarter 2025 revenue at $14.346 million, while actual first-quarter 2026 revenue was $0.935 million.

Guidance 2026 and order pipeline

In the business update of June 25, 2026, MicroVision put a number on its expectations for the first time: $10 million to $15 million of revenue and a 35 to 40 percent gross margin for 2026, plus more than 100 live customer engagements and a bookings opportunity of over $500 million for 2026 through 2030; the guidance was reaffirmed on July 7, 2026. It is supported by a master development agreement dated June 10, 2026 with the world's leading manufacturer of construction and mining equipment. After $0.935 million of revenue in the first quarter of 2026, however, the guidance requires roughly $9 million to $14 million across the remaining three quarters — a forward-looking statement, not an audited figure.

Worth Noting

MicroVision landed on the research list through its filing trail at the U.S. securities regulator, the SEC: six capital-markets documents between June 12 and July 22, 2026 (tier transfer, amendment of the at-the-market program, two registration statements, prospectus supplement, annual meeting results, reverse stock split). Data cut-off for this analysis: August 4, 2026.

Every share count and per-share figure in this analysis is expressly labeled as “before” or “after” the 1-for-15 reverse split of August 1, 2026. According to the Form 8-K of July 22, 2026, split-adjusted trading was scheduled to begin on August 3, 2026 under the unchanged symbol MVIS and with a new CUSIP number, 594960403. In phases like this, automatically computed metrics from data feeds routinely mix both bases.

The 2026 revenue guidance of $10 million to $15 million and the 35 to 40 percent gross margin target come from a shareholder presentation that MicroVision filed on June 25, 2026 as Exhibit 99.1 to a Form 8-K (Item 7.01), and were reaffirmed on July 7, 2026. These are forward-looking statements by the company, not audited results — the next quarterly report (10-Q) is the first hard reconciliation.

The market capitalization reported by the fundamental data was deliberately not used, nor any metric derived from it: immediately after a reverse stock split, data feeds mix prices and share counts from before and after the effective date, so the reported figure is not comparable. The only valuation anchor used is the calculation of 344,645,965 shares (May 28, 2026) against the last price documented in a filing, $0.36 on June 11, 2026 (prospectus supplement 424B5) — roughly $124 million.

Stock Watch

This analysis is as of August 26, 2026. Stock Watch will tell you what's changed at MVIS since then.

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Price history

Chart

Interactive price chart (TradingView).

52-week range: 0.24 $ to 4.70 $ · Last price: 1.60 $ (As of: September 17, 2026)

Key figures

Key figures at a glance

Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.

Basics

Market Cap ?The value of the entire company on the market: share price times total shares outstanding. 0.6$B
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 31m
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 76.5%
Beta ?Volatility versus the overall market: 1 = moves like the market, 2 = twice as much, under 1 = calmer than the market. 1.2

Performance

Perf. 1M ?Price performance over the last month. -52.60%
Perf. 3M ?Price performance over the last 3 months. -48.50%
Perf. 6M ?Price performance over the last 6 months. -67.20%
YTD Performance (%) ?Price performance since the start of the year (Year to Date). -58.50%
52-Week-High Distance ?How far the price sits below its highest point over the last 52 weeks. 0% means the stock is at its year high. -82.1%
Perf. 1Y ?Price performance over the last 12 months. -90.79%
Perf. 3Y ?Price performance over the last 3 years. -95.11%
Perf. 5Y ?Price performance over the last 5 years. -99.15%
Perf. 10Y ?Price performance over the last 10 years. -92.76%
Perf. Since Inception ?Price performance since the first available trading day (08/27/1996) — with a complete history, that is since the IPO. -99.74%

Technical Indicators

MA 38 Days ?Moving average of the last 38 trading days: the smoothed price path. A price above it signals short-term strength. 2.00$
MA 50 Days ?Moving average of the last 50 trading days — the most widely watched medium-term trend line. 1.60$
MA 200 Days ?Moving average of the last 200 trading days — the dividing line between a long-term uptrend and downtrend. 0.9129$
RSI (14) ?Relative Strength Index over 14 days, scale 0 to 100: above 70 counts as overbought, below 30 as oversold. A hint on timing, not a verdict on the company. 46.6
Volatility 30 Days ?Price swings over the last 30 trading days, annualized. The higher the value, the more the price fluctuates. 192.8%
Volatility 250 Days ?Price swings over the last 250 trading days (roughly one market year), annualized. 118.0%

Calculated from the price history · as of 09/18/2026

Valuation

P/E ?Price-to-earnings ratio: how many years of profit does the stock cost? The lower, the cheaper the valuation. No earnings means no P/E.
Forward P/E ?P/E based on expected earnings for the next 12 months instead of past earnings — analysts' bet on the future. 0.0
PEG ?P/E divided by expected earnings growth: puts valuation in relation to growth. Around 1 is considered fair, well above that is pricey.
P/B ?Price-to-book ratio: market value relative to book equity.
P/S ?Price-to-sales ratio: market value divided by annual sales. Important for companies that aren't (yet) profitable. 203.2
EV/EBITDA ?Enterprise value including debt (EV) relative to operating profit before depreciation and amortization (EBITDA) — more comparable than P/E because debt counts too. Extreme values arise when EBITDA is near zero. -13.1
Price/FCF ?Market value divided by free cash flow: how many years of freely available cash does the stock cost? More honest than P/E because cash flow is harder to dress up.

Profitability

Gross Margin ?Gross margin: what's left of sales after only direct production costs are deducted — the product's pricing power. -550.6%
EBIT Margin ?EBIT margin: operating profit as a percentage of sales — the earning power of the core business before interest and taxes.
Net Margin ?Net margin: what's left of sales as profit after ALL costs, interest, and taxes. 0.0%
Return on Equity ?Return on equity: how much profit does the company generate per year on shareholders' equity? -197.3%
Return on Assets ?Return on assets: how much profit the company generates from its total assets (equity and debt combined). -45.0%

Balance Sheet & Safety

Equity Ratio ?Equity ratio: equity as a share of total assets. The higher, the more resilient the balance sheet.
Debt/Equity ?Leverage ratio: financial debt divided by equity. Under 1 is generally seen as solid; negative values mean negative equity.
Altman Z″ ?Edward Altman's bankruptcy early-warning score. We use the Z″ variant, built from four balance-sheet ratios — it is designed for service companies and non-manufacturers and uses book value instead of market value. On that scale: below 1.1 = danger zone, 2.6 and up = safe zone, in between a grey area. Because the classic Altman Z is calculated differently, the two numbers are not directly comparable. The formula does not fit banks, insurers, or real-estate stocks. warning zone -30.12
Piotroski ?Balance-sheet health check by Joseph Piotroski: 9 yes/no criteria on profit, cash flow, leverage, and efficiency. 7+ is very solid, under 3 is a red flag. 4 out of 9

Growth

Sales Growth Last Quarter ?Sales growth in the most recently reported quarter versus the same quarter a year ago (YoY). 58.70%
EPS Growth Last Quarter ?Growth in earnings per share in the most recently reported quarter versus the same quarter a year ago (YoY). 0.00%
Sales Growth (Year) ?Sales growth in the last fiscal year versus the year before. -74.28%
Forward Sales Growth ?Sales growth analysts expect over the next 12 months — an estimate, not a guarantee. 48.15%
Forward EPS Growth ?Earnings-per-share growth analysts expect over the next 12 months — an estimate, not a guarantee.

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage ?Weinstein phases 1 through 4: 1 = basing, 2 = uptrend (the only buy phase), 3 = topping, 4 = downtrend. Measured against the 30-week line. 4
RS Rating ?Relative strength from 1 to 99: an RS of 95 means the stock has outperformed 95% of all stocks. 2
EPS Rating ?Earnings growth rating from 1 to 99 versus all stocks — high values mean above-average earnings growth. 42
Fundamental Rating ?Our own Fundamental Rating: 0 to 100 points with an A+ to F grade. 50 points is the average across the universe, 100 the best possible score. It scores growth, earnings surprises, analyst estimates, margins, cash flow, and balance-sheet safety — every stock percentile-ranked against all others. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below. D (43 out of 100)

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Comparison

Industry comparison

The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.

Industry: Scientific & Technical Instruments

Industry comparison
Company Market cap ($B) P/E EV/EBITDA Gross Margin % EBIT Margin % Sales Growth (Year) % Perf. 1Y %
Microvision Inc MVIS 0.6 -13.1 -550.6 -74.3 -90.8
Keysight Technologies Inc KEYS 60.0 52.9 28.1 63.3 18.8 8.0 91.7
Coherent Inc COHR 58.7 130.0 34.5 37.5 13.6 23.4 186.2
Garmin Ltd GRMN 53.1 30.3 22.3 60.1 24.6 15.1 18.9
Teledyne Technologies Incorporated TDY 27.9 30.8 18.5 43.3 19.0 7.9 8.3
MKS Instruments Inc MKSI 17.5 47.7 19.3 46.9 16.1 9.6 99.6
Fortive Corp FTV 17.0 32.8 16.0 63.2 17.9 -17.5 15.2
Trimble Inc TRMB 13.4 29.4 53.7 71.8 15.9 -2.6 -28.0
Cognex Corporation CGNX 10.1 72.9 36.4 68.9 22.3 8.7 38.9
Median of companies shown 17.5 40.2 22.3 60.1 18.4 8.0 18.9

Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →

Fiscal years

Annual Figures

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

Revenue, operating income and net income per fiscal year $M

Revenue Operating income Net income

2016 · Revenue: 15 $M 2016 · Operating income: -16 $M 2016 · Net income: -16 $M 2017 · Revenue: 11 $M 2017 · Operating income: -24 $M 2017 · Net income: -24 $M 2018 · Revenue: 18 $M 2018 · Operating income: -27 $M 2018 · Net income: -27 $M 2019 · Revenue: 9 $M 2019 · Operating income: -26 $M 2019 · Net income: -25 $M 2020 · Revenue: 3 $M 2020 · Operating income: -14 $M 2020 · Net income: -14 $M 2021 · Revenue: 3 $M 2021 · Operating income: -44 $M 2021 · Net income: -43 $M 2022 · Revenue: 1 $M 2022 · Operating income: -54 $M 2022 · Net income: -53 $M 2023 · Revenue: 7 $M 2023 · Operating income: -89 $M 2023 · Net income: -83 $M 2024 · Revenue: 5 $M 2024 · Operating income: -86 $M 2024 · Net income: -97 $M 2025 · Revenue: 1 $M 2025 · Operating income: -69 $M 2025 · Net income: -95 $M
2016201720182019202020212022202320242025
Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2016 15 -16 -16 -4.76 -15 7 20
2017 11 -24 -24 -5.00 -15 5 30
2018 18 -27 -27 -4.70 -23 4 23
2019 9 -26 -25 -3.35 -24 -4 12
2020 3 -14 -14 -1.46 -16 9 21
2021 3 -44 -43 -4.03 -29 113 130
2022 1 -54 -53 -4.80 -38 90 115
2023 7 -89 -83 -6.80 -67 96 130
2024 5 -86 -97 -6.94 -69 49 121
2025 1 -69 -95 -5.22 -59 56 103

Quarters

Quarterly Figures

Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 1.6 $M Q4 2025: Q1 · 0.6 $M Q1 2025: Q2 · 0.2 $M Q2 2025: Q3 · 0.2 $M Q3 2025: Q4 · 0.2 $M Q4 2026: Q1 · 0.9 $M Q1 2026: Q2 · 1.5 $M Q2

Source: fundamental data

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.14 2 -67.70 -1,888.20 -15 -15
2025: Q1 -0.12 1 -38.40 -4,886.10 -14 -14
2025: Q2 -0.06 0 -91.80 -9,180.00 -13 -13
2025: Q3 -0.05 0 26.80 -5,899.20 -17 -17
2025: Q4 -0.12 0 -86.50 -16,930.90 -15 -16
2026: Q1 -0.08 1 58.70 -2,705.20 -15 -16
2026: Q2 -1.66 -2,666.70 2 650.00 -2,460.00 -19 -19

What Do These Terms Mean?

EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Compare with other stocks →

Screening

Appears in These Scanners

This stock currently matches 12 of our scanner strategies — each hit links to the scanner.

Research

Risk & Weakness

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Outlook

Analysts & Price Target

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Consensus Strong Sell 1 = Strong buy … 5 = Strong sell
Analyst Ratings 2
Price Target (average) 2.00$
Distance to price 25.0% The price target sits 25.0% above the current price.

Distribution of Recommendations

Strong Buy 2
Buy 0
Hold 0
Sell 0
Strong Sell 0

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 -0.13 -0.13 – -0.13 0 1
12/31/2027 -0.17 -0.17 – -0.17 20 1

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Valuation

What is priced in?

Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.

A simplified model calculation — not a forecast and not a recommendation.

AI classification

AI Rating

Sells AI

MicroVision verkauft Wahrnehmungssoftware und Lidar-Sensoren, in denen maschinelles Lernen bzw. „deterministische KI an der Kante“ ausdrücklich Produktbestandteil ist und die genau so an Automobil-, Industrie- und Verteidigungskunden vermarktet werden.

View the full file — quotes, sources, reviewed filings
„Our patented LBS technology combines a MEMS scanning mirror, laser diode light sources, electronics, and optics that are controlled using our proprietary system control algorithms along with edge computing and machine learning in some systems."

Unsere patentierte LBS-Technologie kombiniert einen MEMS-Scanspiegel, Laserdioden-Lichtquellen, Elektronik und Optik, die über unsere proprietären Systemsteuerungs-Algorithmen zusammen mit Edge-Computing und in einigen Systemen maschinellem Lernen gesteuert werden.

10-K · 2026-03-04 · View SEC filing

„Our integrated solution, built on our perception software stack, combines our lidar sensors, both MEMS-based and flash-based, and application software targeted for sale to industrial mobility and autonomy companies, automotive OEMs and Tier 1 suppliers, and defense contractors."

Unsere integrierte Lösung, aufgebaut auf unserem Wahrnehmungs-Software-Stack, verbindet unsere Lidar-Sensoren — sowohl MEMS- als auch Flash-basiert — mit Anwendungssoftware, die zum Verkauf an Unternehmen der industriellen Mobilität und Autonomie, an Automobilhersteller und Tier-1-Zulieferer sowie an Verteidigungsauftragnehmer bestimmt ist.

10-Q · 2025-11-12 · View SEC filing

„Our deterministic AI at the edge enables critical decisions to be made locally and independent of the cloud, leading to faster responses, improved data privacy, and reduced costs."

Unsere deterministische KI an der Kante ermöglicht es, kritische Entscheidungen lokal und unabhängig von der Cloud zu treffen — mit schnelleren Reaktionen, besserem Datenschutz und geringeren Kosten.

10-Q · 2025-11-12 · View SEC filing

„Although we are evaluating and, where we believe appropriate, incorporating the use of AI tools into our operations, such as the use of generative AI tools to assist in the development of code, our use of such tools may subject us to significant competitive, legal, regulatory and other risks, and there can be no assurance that our use of AI tools will enhance our business operations or result in a benefit to us."

Wir prüfen den Einsatz von KI-Werkzeugen in unserem Betrieb und setzen sie ein, wo wir es für angemessen halten — etwa generative KI-Werkzeuge zur Unterstützung bei der Code-Entwicklung. Ihr Einsatz kann uns jedoch erheblichen Wettbewerbs-, Rechts-, Regulierungs- und sonstigen Risiken aussetzen, und es besteht keine Gewähr, dass er unseren Geschäftsbetrieb verbessert oder uns nützt.

10-Q · 2026-05-15 · View SEC filing

Filings Reviewed: 10-Q 2026-05-15 · 10-K 2026-03-04 · 10-Q 2025-11-12 · 10-Q 2025-08-08 · 10-Q 2025-05-12 · 10-K 2025-03-26

Rated on August 4, 2026 · How the Rating Is Built

Growth

Growth Score

Ten checks against the annual reports — each one passed counts a point.

4 of 10 Weak growth
  • Revenue grows by more than 15% a year over three years 22.1%
  • More than 10% revenue growth is expected for the coming year 48.2%
  • Share count grows by less than 3% a year 18.1%
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -4,991.4%
  • Gross margin at 40% or higher and without meaningful erosion -1,435.4%
  • Goodwill from acquisitions does not grow faster than revenue 0.0%
  • Net debt below twice EBITDA 38 m net cash
  • Operating cash flow covers the profits of the last three years 80 m
  • Return on capital at 15% or higher, or up versus two years ago -95.1%
  • Insiders hold at least 10% or are net buyers 1.9%

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Quality check

AAQS

4/10

The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).

  • Sales growth 10Y > 5% -24.3%
  • Exp. sales growth 3Y > 5% 306.6%
  • EBIT growth 10Y > 5%
  • Exp. EBIT growth 3Y > 5% 306.6%
  • Net debt < 4x EBIT
  • EBIT positive, 10Y straight 0
  • Max. EBIT decline < 50%
  • Return on equity > 15% -171.1%
  • ROCE > 15% -95.1%
  • Expected return > 10% 264.1%

View stocks with the full AAQS score · Read the methodology at AlleAktien

Source: fundamental data

Insiders

Insider Transactions

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

Insider Transactions
Date Person Role Type Shares Price Value
Sep 1, 2026 Smith Jada Director Other 4,670 0.00
Sep 1, 2026 Carlile Robert Paul Director Other 4,670 0.00
Sep 1, 2026 Herbst Jeffrey A Director Other 4,670 0.00
Sep 1, 2026 Peterson Laura J. Director Other 4,670 0.00
Sep 1, 2026 Schabert Peter Director Other 4,670 0.00

View all insider transactions →

The company

About the Company

MicroVision, Inc. entwickelt und vermarktet Lidar-Sensoren und Wahrnehmungslösungen in den USA, Deutschland und international.

Employees
190
Headquarters
Redmond, WA
Address
18390 NE 68th Street, 98052 Redmond, United States
Phone
425 936 6847
IPO Date
08/27/1996
ISIN
US5949603048
Stock Split
1:15 on 08/03/2026
Stock Split
1:8 on 02/21/2012

Management

Management
Name Title Birth Year
Glen W. DeVos CEO & Director 1962
Simon Biddiscombe Executive Vice Chair of the Board 1967
Drew G. Markham Senior VP, General Counsel & Secretary, and Head of People Operations 1968
Christine Chambers CFO and Principal Financial & Accounting Officer 1977
Fabio Laura Vice President of Product Engineering & Operations
James Byun Chief Commercial Officer
James Edward Johnston Controller 1969
Lindsey L. Stibbard Paralegal

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Filings

Company Filings (8-K)

An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).

  • 08/31/2026 MICROVISION, INC. (MVIS): Other Events; Financial Statements and Exhibits SEC ↗
  • 08/17/2026 MICROVISION, INC. (MVIS): Entry into a Material Definitive Agreement; Other Events; Financial Statements and Exhibits SEC ↗
  • 08/10/2026 MICROVISION, INC. (MVIS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits SEC ↗
  • 08/06/2026 MICROVISION, INC. (MVIS): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
  • 07/22/2026 MICROVISION, INC. (MVIS): Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Financial Statements and Exhibits SEC ↗
  • 07/13/2026 MICROVISION, INC. (MVIS): Submission of Matters to a Vote of Security Holders SEC ↗
  • 07/07/2026 MICROVISION, INC. (MVIS): Regulation FD Disclosure; Financial Statements and Exhibits SEC ↗

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?